Clinical spectrum and treatment outcomes in variants of Guillain-Barr� syndrome: a case series

Simple item page
dc.contributor.authorM., Y.en_US
dc.contributor.authorK., M.en_US
dc.date.accessioned2024-09-24T09:21:37Z
dc.date.available2024-09-24T09:21:37Z
dc.date.issued2024-04
dc.description.abstractGuillain-Barr� syndrome (GBS) is an autoimmune polyradiculoneuropathy that is acute, typically severe, and fulminant. GBS has an incidence of 0.81-1.89 (median 1.11) per 100,000 person-years, and men are slightly more susceptible to GBS than females. 70% of individuals acquire this acute flaccid paralysis condition within 1-4 weeks following a respiratory infection or diarrhoea (especially Campylobacter jejuni). There are several identified subtypes of GBS, with acute inflammatory demyelinating polyneuropathy (AIDP) being the most prevalent. Additionally, there are two "axonal" subtypes: acute motor axonal neuropathy (AMAN) and acute motor sensory axonal neuropathy (AMSAN), both of which are clinically severe. The clinical trial of ophthalmoplegia, ataxia, and areflexia characterizes a different subtype called Miller Fisher syndrome (MFS) linked to anti-GQ1b antibodies. The patient's medical history, along with neurological, electrophysiological, and cerebrospinal fluid tests, are used to diagnose GBS. Intravenous immunoglobulin (IVIG) and plasma exchange are effective treatments; however, newer approaches are required because 25% of patients eventually need mechanical ventilation, 20% are unable to walk, and 2-5% of patients may experience relapses.en_US
dc.identifier.affiliationsDepartment of Neurology, Government Stanley Medical College, Chennai, Tamil Nadu, Indiaen_US
dc.identifier.affiliationsDepartment of Neurology, Government Stanley Medical College, Chennai, Tamil Nadu, Indiaen_US
dc.identifier.citationM. Y., K. M.. Clinical spectrum and treatment outcomes in variants of Guillain-Barr� syndrome: a case series. International Journal of Research in Medical Sciences. 2024 Apr; 12(4): 1242-1248en_US
dc.identifier.issn2320-6071
dc.identifier.issn2320-6012
dc.identifier.placeIndiaen_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/233987
dc.languageenen_US
dc.publisherMedip Academyen_US
dc.relation.issuenumber4en_US
dc.relation.volume12en_US
dc.source.urihttps://doi.org/10.18203/2320-6012.ijrms20240848en_US
dc.subjectGBSen_US
dc.subjectAIDPen_US
dc.subjectAMANen_US
dc.subjectAMSANen_US
dc.subjectMFSen_US
dc.subjectIVIGen_US
dc.titleClinical spectrum and treatment outcomes in variants of Guillain-Barr� syndrome: a case seriesen_US
dc.typeJournal Articleen_US
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
ijrms2024v12n4p1242.pdf
Size:
157.32 KB
Format:
Adobe Portable Document Format
Download
Collections
International Journal of Research in Medical Sciences